ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
June 18, 2021Harrow Health, Inc. an ophthalmic-focused healthcare company, today announced the closing of its underwritten registered public offering of $20 million aggregate principal amount of 8.625% senior notes due 2026 (the "Notes") -
Harrow Health Announces Launch of Mayfield Pharmaceuticals
August 01, 2019Harrow Health has filed a Form 8-K with the Securities and Exchange Commission containing a corporate presentation for its subsidiary, Mayfield Pharmaceuticals.
Pharma Sources Insight January 2025
